Clinical Trial

A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis

Study acronym: BARRIER
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to determine if viral infection with the common cold leads to an exacerbation in participants with bronchiectasis. The investigators will compare the participants with bronchiectasis to a group of healthy participants. The main questions it aims to answer are: * Does viral infection with the common cold lead to an exacerbation in bronchiectasis? * Does the immune response differ to that of a healthy participant? Participants will attend for a screening visit to see if they are eligible. All participants who are eligible and have consented to take part will have baseline investigations done including blood tests and a bronchoscopy. They will be given a spray of a virus that causes the common cold into their nose. They will then be followed up over the next 6 weeks with some of the following procedures at each study visit; spirometry, nasosorption, nasal lavage, nasal brushing, blood test, sputum collection and a bronchoscopy. Participants will be asked to keep a daily record of their symptoms throughout the study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-09.
Trial Details
NCT Number NCT06931002
Lead Sponsor Imperial College London
Collaborators: Imperial College Healthcare NHS Trust
Conditions Bronchiectasis Adult, Bronchiectasis With Acute Exacerbation, Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa, Viral Infection, Rhinovirus Infection
Enrollment 54 participants
Start Date 2024-07-24
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-09